{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:24:06Z","timestamp":1767137046689,"version":"build-2238731810"},"publisher-location":"Cham","reference-count":40,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030308735","type":"print"},{"value":"9783030308742","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-30874-2_31","type":"book-chapter","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T12:17:36Z","timestamp":1568981856000},"page":"397-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Digital Business Model Patterns of Big Pharmaceutical Companies - A Cluster Analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-9604","authenticated-orcid":false,"given":"Cyrine","family":"Tangour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Gebauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4170-013X","authenticated-orcid":false,"given":"Luise","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herwig","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,21]]},"reference":[{"key":"31_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-41144-6","volume-title":"Exploring the Field of Business Model Innovation: New Theoretical Perspectives","author":"O Gassmann","year":"2016","unstructured":"Gassmann, O., Frankenberger, K., Sauer, R.: Exploring the Field of Business Model Innovation: New Theoretical Perspectives. Palgrave Pivot. Palgrave Macmillan, Cham (2016)"},{"key":"31_CR2","volume-title":"Business Model Generation: A Handbook for Visionaries, Game Changers, and Challengers","author":"A Osterwalder","year":"2010","unstructured":"Osterwalder, A., Pigneur, Y.: Business Model Generation: A Handbook for Visionaries, Game Changers, and Challengers. Wiley, Hoboken (2010)"},{"issue":"01","key":"31_CR3","doi-asserted-by":"publisher","first-page":"1340003","DOI":"10.1142\/s1363919613400033","volume":"17","author":"N Abdelkafi","year":"2013","unstructured":"Abdelkafi, N., Makhotin, S., Posselt, T.: Business model innovations for electric mobility: what can be learned from existing business model patterns? Int. J. Innov. Manag. 17(01), 1340003 (2013). \n                    https:\/\/doi.org\/10.1142\/s1363919613400033","journal-title":"Int. J. Innov. Manag."},{"issue":"01","key":"31_CR4","doi-asserted-by":"publisher","first-page":"1750004","DOI":"10.1142\/s1363919617500049","volume":"21","author":"G Remane","year":"2017","unstructured":"Remane, G., Hanelt, A., Tesch, J.F., et al.: The business model pattern database\u2014: a tool for systematic business model innovation. Int. J. Innov. Manag. 21(01), 1750004 (2017). \n                    https:\/\/doi.org\/10.1142\/s1363919617500049\n                    \n                  . (61 Pages)","journal-title":"Int. J. Innov. Manag."},{"key":"31_CR5","volume-title":"The Business Model Navigator: 55 Models that Will Revolutionise Your Business","author":"O Gassmann","year":"2014","unstructured":"Gassmann, O., Frankenberger, K., Csik, M.: The Business Model Navigator: 55 Models that Will Revolutionise Your Business. Pearson, Harlow (2014)"},{"key":"31_CR6","unstructured":"Sprenger, M., Mettler, T.: On the utility of e-health business model design patterns. In: 24th European Conference on Information Systems (ECIS) 2016. Bogazi\u00e7i University, Istanbul, Turkey, pp. 1\u201316 (2016)"},{"key":"31_CR7","series-title":"Communications in Computer and Information Science","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-3-319-44672-1_14","volume-title":"Building Sustainable Health Ecosystems","author":"M Sprenger","year":"2016","unstructured":"Sprenger, M.: Supporting the viability of e-health services with pattern-based business model design. In: Li, H., Nyk\u00e4nen, P., Suomi, R., Wickramasinghe, N., Wid\u00e9n, G., Zhan, M. (eds.) WIS 2016. CCIS, vol. 636, pp. 161\u2013175. Springer, Cham (2016). \n                    https:\/\/doi.org\/10.1007\/978-3-319-44672-1_14"},{"issue":"1","key":"31_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/0149206316675927","volume":"43","author":"NJ Foss","year":"2017","unstructured":"Foss, N.J., Saebi, T.: Fifteen years of research on business model innovation. JOM 43(1), 200\u2013227 (2017). \n                    https:\/\/doi.org\/10.1177\/0149206316675927","journal-title":"JOM"},{"issue":"2","key":"31_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.respol.2013.10.014","volume":"43","author":"R Bohnsack","year":"2014","unstructured":"Bohnsack, R., Pinkse, J., Kolk, A.: Business models for sustainable technologies: exploring business model evolution in the case of electric vehicles. Res. Policy 43(2), 284\u2013300 (2014). \n                    https:\/\/doi.org\/10.1016\/j.respol.2013.10.014","journal-title":"Res. Policy"},{"issue":"1","key":"31_CR10","first-page":"209","volume":"11","author":"G Mehralian","year":"2012","unstructured":"Mehralian, G., Rajabzadeh Gatari, A., Morakabati, M., et al.: Developing a suitable model for supplier selection based on supply chain risks: an empirical study from Iranian pharmaceutical companies. Iran J. Pharm. Res. 11(1), 209\u2013219 (2012)","journal-title":"Iran J. Pharm. Res."},{"issue":"2\u20133","key":"31_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.lrp.2010.02.001","volume":"43","author":"V Sabatier","year":"2010","unstructured":"Sabatier, V., Mangematin, V., Rousselle, T.: From recipe to dinner: business model portfolios in the European biopharmaceutical industry. Long Range Plan. 43(2\u20133), 431\u2013447 (2010). \n                    https:\/\/doi.org\/10.1016\/j.lrp.2010.02.001","journal-title":"Long Range Plan."},{"issue":"2","key":"31_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1468-0009.2009.00560.x","volume":"87","author":"K Chalkidou","year":"2009","unstructured":"Chalkidou, K., Tunis, S., Lopert, R., et al.: Comparative effectiveness research and evidence-based health policy: experience from four countries. Milbank Q. 87(2), 339\u2013367 (2009). \n                    https:\/\/doi.org\/10.1111\/j.1468-0009.2009.00560.x","journal-title":"Milbank Q."},{"key":"31_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-77636-9","volume-title":"Leading pharmaceutical innovation: trends and drivers for growth in the pharmaceutical industry","author":"O Gassmann","year":"2008","unstructured":"Gassmann, O., Reepmeyer, G., Zedtwitz, M.: Leading pharmaceutical innovation: trends and drivers for growth in the pharmaceutical industry, 2nd edn. Springer, Heidelberg (2008). \n                    https:\/\/doi.org\/10.1007\/978-3-540-77636-9","edition":"2"},{"issue":"1","key":"31_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12967-016-0838-4","volume":"14","author":"A Schuhmacher","year":"2016","unstructured":"Schuhmacher, A., Gassmann, O., Hinder, M.: Changing R&D models in research-based pharmaceutical companies. J. Transl. Med. 14(1), 105 (2016). \n                    https:\/\/doi.org\/10.1186\/s12967-016-0838-4","journal-title":"J. Transl. Med."},{"key":"31_CR15","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/cpt.1354","volume":"105","author":"M Lee","year":"2019","unstructured":"Lee, M., Ly, H., M\u00f6ller, C.C., et al.: Innovation in regulatory science is meeting evolution of clinical evidence generation. Clin. Pharmacol. Ther. 105, 886\u2013898 (2019). \n                    https:\/\/doi.org\/10.1002\/cpt.1354","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"31_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/ppc.12112","volume":"52","author":"MD Pinto","year":"2016","unstructured":"Pinto, M.D., Greenblatt, A.M., Hickman, R.L., et al.: Assessing the critical parameters of eSMART-MH: a promising avatar-based digital therapeutic intervention to reduce depressive symptoms. Perspect. Psychiatr. Care 52(3), 157\u2013168 (2016). \n                    https:\/\/doi.org\/10.1111\/ppc.12112","journal-title":"Perspect. Psychiatr. Care"},{"issue":"1","key":"31_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/cpt.1036","volume":"104","author":"O Sverdlov","year":"2018","unstructured":"Sverdlov, O., van Dam, J., Hannesdottir, K., et al.: Digital therapeutics: an integral component of digital innovation in drug development. Clin. Pharmacol. Ther. 104(1), 72\u201380 (2018)","journal-title":"Clin. Pharmacol. Ther."},{"key":"31_CR18","unstructured":"Inc A HealthKit - Apple Developer. \n                    https:\/\/developer.apple.com\/healthkit\/\n                    \n                  . Accessed 15 Feb 2019"},{"key":"31_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000479951","volume":"1","author":"C Rodarte","year":"2017","unstructured":"Rodarte, C.: Pharmaceutical perspective: how digital biomarkers and contextual data will enable therapeutic environments. Digit Biomark. 1, 73\u201381 (2017). \n                    https:\/\/doi.org\/10.1159\/000479951","journal-title":"Digit Biomark."},{"issue":"1","key":"31_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/cpt.1092","volume":"104","author":"B Smith","year":"2018","unstructured":"Smith, B., Sverdlov, A.: Digital technology: the future is bright. Clin. Pharmacol. Ther. 104(1), 9\u201311 (2018)","journal-title":"Clin. Pharmacol. Ther."},{"key":"31_CR21","unstructured":"Robert Wood Johnson Foundation: Assessment Report (2013). \n                    https:\/\/www.rwjf.org\/en\/library\/research\/2013\/12\/2013-assessment-report.html\n                    \n                  . Accessed 15 Feb 2019"},{"key":"31_CR22","unstructured":"Ernst & Young Global Limited: How to manage disruptions to gain competitive advantage (2017). \n                    https:\/\/www.ey.com\/en_gl\/life-sciences\/how-to-manage-disruptions-to-gain-competitive-advantage\n                    \n                  . Accessed 15 Feb 2019"},{"issue":"3","key":"31_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5437\/08953608x5403009","volume":"54","author":"PA Koen","year":"2011","unstructured":"Koen, P.A., Bertels, H.M.J., Elsum, I.R.: The three faces of business model innovation: challenges for established firms. Res. Technol. Manag. 54(3), 52\u201359 (2011). \n                    https:\/\/doi.org\/10.5437\/08953608x5403009","journal-title":"Res. Technol. Manag."},{"issue":"2\u20133","key":"31_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.lrp.2009.07.010","volume":"43","author":"H Chesbrough","year":"2010","unstructured":"Chesbrough, H.: Business model innovation: opportunities and barriers. Long Range Plan. 43(2\u20133), 354\u2013363 (2010). \n                    https:\/\/doi.org\/10.1016\/j.lrp.2009.07.010","journal-title":"Long Range Plan."},{"key":"31_CR25","doi-asserted-by":"crossref","unstructured":"Chesbrough, H., Rosenbloom, R.S.: The role of business model in capturing value from innovation: evidence from Xerox Corporation\u2019s technology spinn-off companies, 11(3), 529\u2013555 (2002)","DOI":"10.1093\/icc\/11.3.529"},{"issue":"5","key":"31_CR26","first-page":"86","volume":"80","author":"J Magretta","year":"2002","unstructured":"Magretta, J.: Why business models Matter. Harv. Bus. Rev. 80(5), 86\u201392 (2002)","journal-title":"Harv. Bus. Rev."},{"key":"31_CR27","doi-asserted-by":"crossref","unstructured":"Osterwalder, A., Pigneur, Y., Tucci, C.L.: Clarifying business models: origins, present, and future of the concept. Commun. Assoc. Inf. Syst. (15), 1\u201343 (2005)","DOI":"10.17705\/1CAIS.01601"},{"issue":"3","key":"31_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bushor.2004.10.014","volume":"48","author":"SM Shafer","year":"2005","unstructured":"Shafer, S.M., Smith, H.J., Linder, J.C.: The power of business models. Bus. Horiz. 48(3), 199\u2013207 (2005). \n                    https:\/\/doi.org\/10.1016\/j.bushor.2004.10.014","journal-title":"Bus. Horiz."},{"key":"31_CR29","unstructured":"Schallmo, D., Brecht, L.: Business model innovation in business-to-business markets -: procedure and examples. Paper presented at the 3rd ISPIM Innovation Symposium: \u201cManaging the Art of Innovation: Turning Concepts into Reality\u201d, Quebec City, Canada (2010)"},{"issue":"3","key":"31_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/radm.12071","volume":"44","author":"P Spieth","year":"2014","unstructured":"Spieth, P., Schneckenberg, D., Ricart, J.E.: Business model innovation - state of the art and future challenges for the field. R&D Manag. 44(3), 237\u2013247 (2014). \n                    https:\/\/doi.org\/10.1111\/radm.12071","journal-title":"R&D Manag."},{"issue":"1","key":"31_CR31","first-page":"46","volume":"51","author":"MH Morris","year":"2013","unstructured":"Morris, M.H., Shirokova, G., Shatalov, A.: The business model and firm performance: the case of russian food service ventures. JSBM 51(1), 46\u201365 (2013)","journal-title":"JSBM"},{"key":"31_CR32","unstructured":"Wikipedia: List of largest pharmaceutical companies by revenue \u2013 Wikipedia (2019). \n                    https:\/\/en.wikipedia.org\/w\/index.php?oldid=883348703\n                    \n                  . Accessed 14 Feb 2019"},{"key":"31_CR33","unstructured":"Top 50 Global Pharma Companies - 2018 (Pharmaceutical Executive)\u2014Ranking The Brands. \n                    https:\/\/www.rankingthebrands.com\/The-Brand-Rankings.aspx?rankingID=370\n                    \n                  . Accessed 14 Feb 2019"},{"key":"31_CR34","unstructured":"Health Care Companies. \n                    https:\/\/www.nasdaq.com\/screening\/companies-by-industry.aspx?industry=Health+Care\n                    \n                  . Accessed 14 Feb 2019"},{"key":"31_CR35","volume-title":"Business Research Methods","author":"A Bryman","year":"2011","unstructured":"Bryman, A., Bell, E.: Business Research Methods, 3rd edn. Oxford University Press, Oxford (2011)","edition":"3"},{"issue":"9","key":"31_CR36","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"H-F Hsieh","year":"2005","unstructured":"Hsieh, H.-F., Shannon, S.E.: Three approaches to qualitative content analysis. Qual. Health Res. 15(9), 1277\u20131288 (2005). \n                    https:\/\/doi.org\/10.1177\/1049732305276687","journal-title":"Qual. Health Res."},{"issue":"4","key":"31_CR37","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3917\/mana.134.0298","volume":"13","author":"C\u00e9sar CAMIS\u00d3N","year":"2010","unstructured":"Camis\u00f3n, C., Villar-L\u00f3pez, A.: Business models in Spanish industry: a taxonomy-based efficacy analysis. M@n@gement 13(4), 298 (2010). \n                    https:\/\/doi.org\/10.3917\/mana.134.0298","journal-title":"M@n@gement"},{"key":"31_CR38","unstructured":"Communications BAG FDA grants breakthrough device designation to artificial intelligence software for CTEPH pattern recognition from Bayer and MSD - Bayer News. \n                    https:\/\/media.bayer.com\/baynews\/baynews.nsf\/id\/FDA-grants-breakthrough-device-designation-artificial-intelligence-software-CTEPH-pattern\n                    \n                  . Accessed 14 Feb 2019"},{"key":"31_CR39","unstructured":"ORILISSA\u2122 (elagolix) 150\u00a0mg or 200\u00a0mg Tablets (2019). \n                    https:\/\/www.orilissa.com\/about\/what-is-orilissa\n                    \n                  . Accessed 15 Feb 2019"},{"key":"31_CR40","unstructured":"Mobihealthnews: FDA\u2019s new draft guidance could hinder applications for digital combination products (2019). \n                    https:\/\/www.mobihealthnews.com\/content\/fdas-new-draft-guidance-could-hinder-applications-digital-combination-products\n                    \n                  . Accessed 15 Feb 2019"}],"updated-by":[{"DOI":"10.1007\/978-3-030-30874-2_32","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000}}],"container-title":["Lecture Notes in Business Information Processing","Digital Economy. Emerging Technologies and Business Innovation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-30874-2_31","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T20:37:34Z","timestamp":1571776654000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-30874-2_31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030308735","9783030308742"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-30874-2_31","relation":{},"ISSN":["1865-1348","1865-1356"],"issn-type":[{"value":"1865-1348","type":"print"},{"value":"1865-1356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"21 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"23 October 2019","order":2,"name":"change_date","label":"Change Date","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"In the originally published version of this chapter, the name of the fourth author Herwig Winkler was incorrect. The name of the author has been corrected.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"ICDEc","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Conference on Digital Economy","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Beirut","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Lebanon","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2019","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"15 April 2019","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"18 April 2019","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"4","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"icdec2019","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/www.aten.tn\/ICDEc2019\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Double-blind","order":1,"name":"type","label":"Type","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"EasyChair","order":2,"name":"conference_management_system","label":"Conference Management System","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"89","order":3,"name":"number_of_submissions_sent_for_review","label":"Number of Submissions Sent for Review","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"31","order":4,"name":"number_of_full_papers_accepted","label":"Number of Full Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"0","order":5,"name":"number_of_short_papers_accepted","label":"Number of Short Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"35% - The value is computed by the equation \"Number of Full Papers Accepted \/ Number of Submissions Sent for Review * 100\" and then rounded to a whole number.","order":6,"name":"acceptance_rate_of_full_papers","label":"Acceptance Rate of Full Papers","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"3,38","order":7,"name":"average_number_of_reviews_per_paper","label":"Average Number of Reviews per Paper","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"1,74","order":8,"name":"average_number_of_papers_per_reviewer","label":"Average Number of Papers per Reviewer","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"Yes","order":9,"name":"external_reviewers_involved","label":"External Reviewers Involved","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}}]}}